Can Scar Tissue Spread and Grow to Other Areas?

Ordinary scar tissue stays put. A surgical incision on your abdomen, a scraped knee, or a healed paper cut will leave a mark, but that mark does not migrate across your skin or seed new scars in distant body parts. There are, however, real exceptions to this reassuring rule, and they are worth understanding. Keloid scars can creep well beyond the edges of the original wound. Internal scar tissue from surgery can form sticky bands between organs that were never injured. And fibrosis inside organs like the lungs or liver can progress over time in ways that feel a lot like “spreading.” The answer depends entirely on what kind of scar tissue you are talking about.

Why Normal Scars Stay Where They Are

When skin is cut or torn, fibroblasts rush to the site and lay down collagen to close the gap. Once the wound is sealed, those fibroblasts slow down, and the scar gradually remodels over months or years, often becoming flatter and paler. The whole process is self-limiting: once the repair job is done, the signals that drove collagen production wind down. For the vast majority of people and the vast majority of wounds, the scar never gets any larger than the injury that caused it. It certainly does not hop to the other side of the body.

This self-limiting behavior is regulated in part by macrophages, which orchestrate both wound closure and the switch from active repair to quiet remodeling. They promote fibroblast activity while a wound is open and help rein it in afterward. When that signaling goes wrong, scar tissue can overshoot its boundaries, but even then the mechanism is local, not systemic.

Keloids and the Illusion of Spreading

Keloids are the clearest example of scar tissue that genuinely grows beyond the original wound. Unlike a hypertrophic scar, which may be raised and red but stays within the wound’s footprint, a keloid extends outward into skin that was never injured. This horizontal growth beyond the wound border is actually the defining feature that distinguishes keloids from hypertrophic scars, and it remains the strongest argument that the two are fundamentally different conditions rather than points on a spectrum.¹

The expansion of a keloid can look alarming. A small ear piercing can produce a grape-sized lump. A chest incision can leave a wide, ropy ridge that extends inches beyond the original cut. People who are prone to keloids sometimes develop them at multiple wound sites across their body, which can create the impression that the scar tissue is “spreading” from one place to another. In reality, each keloid forms independently at its own wound site. The underlying tendency is systemic, meaning your biology makes you prone to it everywhere, but the scars themselves do not send out scouts.

Genetics play a real role here. A cross-sectional study in Burkina Faso found that family history and certain genetic variations in transforming growth factor beta receptors were associated with having keloids at multiple body sites.² That fits with the broader observation that keloid susceptibility runs in families and is more common in people with darker skin tones. It is not a single keloid colonizing new territory; it is a genetic predisposition expressing itself wherever the skin is wounded.

What Drives a Keloid to Keep Growing

Inside a keloid, fibroblasts behave as though the wound never closed. They keep producing collagen long after repair should have finished. Research on the molecular signaling behind this points to the TGF-beta pathway, a cascade of signals that normally tells fibroblasts to ramp up collagen production during wound healing and then quiet down. In keloid fibroblasts, this pathway stays persistently active.³

Recent work on epigenetics adds a layer to this. Fibroblasts in keloids and other fibrotic scars appear to acquire a kind of cellular memory that locks them into a collagen-producing state. Changes in how DNA is chemically tagged and how certain regulatory RNA molecules behave can keep these cells acting like wound-repair machines years after the original injury has healed.⁴ These epigenetic changes affect fibroblast behaviors ranging from proliferation to migration, helping explain why keloids resist the body’s normal “stop building” signals.⁵

Blood vessel growth also feeds the problem. Excess formation of new blood vessels in scar tissue supplies the overactive fibroblasts with nutrients and growth signals. Research has shown that higher levels of vascular endothelial growth factor (VEGF) push wounds toward heavier scarring, and blocking VEGF can reduce scar formation.⁶ Uncontrolled vessel growth and failed vessel regression after inflammation also contribute to pathological scarring.⁷

Adhesions, or When Scar Tissue Forms Where You Never Had a Wound

Internal scar tissue is a different story from anything that happens on the skin. After abdominal surgery, the body can form bands of fibrous tissue called adhesions that stick organs and tissues together. These adhesions form at sites where the lining of the abdominal cavity was disturbed during the operation, and they affect the majority of abdominal surgery patients. The annual clinical burden of adhesion-related complications exceeds $1.7 billion in the United States alone.⁸

Adhesions are not the original wound’s scar tissue “spreading” in a strict sense. They form because surgery damages the peritoneum, the thin membrane that lines the abdomen and coats the organs, in multiple spots. When those damaged surfaces heal, they can fuse to nearby structures. The result is a tough, vascularized, and even innervated band of tissue connecting structures that normally slide freely against each other. This can cause chronic pain, bowel obstruction, and fertility problems.

Postoperative peritoneal adhesion remains a common complication with limited effective prevention strategies.⁹ Research into sprayable surgical sealants and anti-inflammatory agents is ongoing, but no single approach reliably eliminates the risk.¹⁰ For someone who has had multiple abdominal surgeries, the cumulative adhesion burden can be significant, and each additional surgery risks creating more.

Fibrosis Inside Organs

The word “fibrosis” essentially means scarring inside an organ, and it can absolutely progress over time. In the lungs, conditions like idiopathic pulmonary fibrosis involve a process where normal lung tissue is gradually replaced by stiff scar tissue. The fibrosis does not jump from the lungs to, say, the kidneys, but within the lung itself it can spread from one area to another as the disease advances.¹¹ A key driver is a process in which epithelial cells transform into fibroblast-like cells that produce excess collagen, progressively stiffening the tissue.¹²

Liver fibrosis follows a similar pattern. Chronic liver injury from alcohol, hepatitis, or fatty liver disease triggers ongoing repair cycles. Each cycle lays down more scar tissue until, in severe cases, the organ becomes cirrhotic. Ultrasound-based elastography techniques can now measure how stiff the liver has become, giving doctors a way to track fibrosis progression without a biopsy.¹³

The heart is another organ where scar tissue can have consequences far beyond the original damage. After a heart attack, the dead muscle is replaced by scar tissue that cannot contract. That stiff patch forces the remaining healthy muscle to work harder, which can trigger biochemical remodeling even in parts of the heart that were not directly injured.¹⁴ This is not the scar itself spreading, but its downstream effects rippling outward.

Endometriosis and Fibrotic Adhesions in the Pelvis

Endometriosis is a condition in which tissue resembling the uterine lining grows outside the uterus. These ectopic lesions bleed periodically, triggering repeated cycles of inflammation and repair that produce dense fibrotic adhesions. The resulting scar tissue can bind pelvic organs together, distort anatomy, and cause severe pain.¹⁵

This is one of the closest real-world examples of scar tissue appearing to “spread” through a body region. The fibrotic adhesions in endometriosis can involve the ovaries, fallopian tubes, bowel, and bladder, far from where any single lesion started. The spread is driven by the disease process itself, with new endometrial implants seeding new sites of inflammation and new rounds of scarring, rather than the scar tissue migrating on its own.

The Role of Mechanical Forces

Physical tension on a healing wound is one of the strongest predictors of excessive scarring. Wounds in high-tension areas like the chest, shoulders, and joints are far more likely to develop thick, raised scars than wounds in low-tension areas like the eyelids. Biomechanical forces including tension, pressure, and tissue stiffness significantly influence collagen deposition and tissue remodeling during healing.¹⁶

Animal research has shown that mechanical tension can directly promote hypertrophic scar formation, in part by increasing nerve density and nerve growth factor expression in the scar.¹⁷ This means a scar under constant stretch can become thicker and more symptomatic over time, giving the impression of growth even when it is not expanding into new tissue. Understanding this helps explain why pressure garments and silicone sheeting, which reduce tension and maintain moisture, are standard tools for managing scars after burns and surgery.

Treating and Preventing Scar Overgrowth

If you already have a keloid or a hypertrophic scar that seems to be growing, several treatments can flatten it and prevent further expansion. The most widely used clinical approach is intralesional corticosteroid injection, often combined with 5-fluorouracil and a local anesthetic. Multiple randomized trials and meta-analyses support the effectiveness of this combination in reducing scar height, redness, and symptoms like pain and itching.¹⁸ In one prospective study of ear keloids treated with steroid injections, 98% of patients had a complete response.¹⁹

For keloids that recur after surgical removal, adjuvant radiation therapy can help prevent regrowth. Electron beam radiation and brachytherapy are the two most commonly used modalities.²⁰ Long-term data on electron beam therapy after keloid excision showed local control rates of about 93% at one year, dropping to around 68% at ten years, with most recurrences appearing within the first year.²¹

Prevention is sometimes more practical than treatment. Pressure garments have been shown to reduce hypertrophic scarring after burns, with one randomized trial finding that pressure alone was as effective as pressure combined with silicone.²² Topical silicone, applied as a gel or a sheet, is another first-line preventive measure. A randomized trial comparing the two forms found that silicone gel produced better results than silicone gel sheets in terms of pigmentation, vascularity, scar height, and pliability.²³

When Scar Tissue Becomes Something Worse

One genuinely dangerous way scar tissue can “change” over time is through malignant transformation. A Marjolin ulcer is a cancer, most commonly a squamous cell carcinoma, that arises within a chronic wound or old burn scar. These are rare, but they tend to be aggressive.²⁴ The transformation is driven by chronically impaired tissue turnover in the scar, creating an environment where cells are more likely to accumulate mutations.²⁵

Marjolin ulcers typically appear decades after the original injury, most often in burn scars that never fully healed or that repeatedly break down. Any chronic wound or scar that suddenly changes, develops an ulcer that does not heal, or starts growing after years of stability warrants a medical evaluation. This is not scar tissue spreading in the usual sense, but it is a scenario where scar tissue undergoes a transformation that can then spread the way any cancer does.

Dupuytren’s Contracture and Localized Fibromatosis

Some fibrotic conditions create scar-like tissue that does progress within a defined region without any wound to trigger it. Dupuytren’s contracture is a hereditary condition in which progressive fibrosis of the connective tissue in the palm gradually pulls the fingers into a bent position. It is not a response to injury but rather an autonomous fibrotic process that advances over years. Surgical removal of the affected tissue is the standard treatment, but recurrence rates range from about 2% to 39% depending on the study.²⁶

Dupuytren’s is a useful example because it blurs the line between scar tissue and a fibroproliferative disease. The tissue it produces looks and behaves a lot like scar tissue, rich in collagen and fibroblasts, but it forms without trauma and continues advancing unless treated. People with Dupuytren’s sometimes develop similar fibrotic nodules on the soles of their feet or other connective tissues, reinforcing the idea that this is a systemic tendency rather than a single scar gone rogue.

Glial Scarring in the Brain and Spinal Cord

Scar tissue is not exclusive to skin and soft tissue. After injury to the brain or spinal cord, support cells called glia form a dense scar around the damaged area. This glial scar acts as both a physical and chemical barrier, walling off the injury site but also blocking the regrowth of nerve fibers. The scar triggers immune cell infiltration and creates an inhibitory environment that limits functional recovery and can contribute to lasting neurological deficits.²⁷

Glial scars do not spread through the nervous system the way cancer might, but their inhibitory effects extend beyond the scar itself. Chemical signals released by the scar suppress nerve regeneration in the surrounding area, so the functional impact is larger than the physical footprint of the scar would suggest. This is why spinal cord injuries often produce permanent paralysis despite the actual zone of damage being relatively small.

Why Some Animals Do Not Scar at All

If you want perspective on how unusual human scarring is in the biological world, consider the axolotl. These salamanders can heal full-thickness skin wounds without forming any scar tissue at all, regenerating normal skin complete with its original structure. Research has found that their healing process involves substantially less blood clotting, fewer inflammatory cells, and a longer delay before new connective tissue is laid down, all of which appear to be features, not bugs.²⁸ The TGF-beta signaling pathway, the same one implicated in keloid overgrowth in humans, appears to function differently in axolotls in ways that favor regeneration over scar formation.²⁹

Human fetuses also heal with less scarring early in development, and scarless fetal wounds have been shown to have lower levels of VEGF and less blood vessel formation than wounds that do scar.⁶ Understanding these differences is an active area of regenerative medicine research, though we are still a long way from being able to coax adult human wounds to heal without scarring.